US Group Raises Pricing Recommendation for Gilead's Remdesivir in Covid-19

The drugmaker has signed licensing agreements with a bevy of Indian drugmakers including Cipla Ltd and Hetero Labs Ltd.
June 25, 2020 at 07:21AM
from Top World News- News18.com https://ift.tt/2NvHFtG